Edwardsiella tarda is a bacterium that is associated with both an asymptomatic oral carrier state and selflimiting diarrhoeal illness in humans. We herein report a case of sepsis and liver abscess caused by E. tarda and review the patients with E. tarda sepsis who presented at our hospital. An 85-year-old woman developed enterocolitis and sepsis caused by E. tarda. She was administered intensive care and thus was able to soon show a good recovery, however, she subsequently developed a liver abscess. During a complicated course, she continued to be treated with antibiotics and after a successful course was discharged on the 44th day after admission.
Introduction
Edwardsiella tarda belongs to the Enterobacteriaceae family and it is an uncommon pathogen in humans. It sometimes causes oral infections, but most hosts are usually in an asymptomatic carrier state (1) . Sepsis caused by E. tarda is said to develop in immunocompromised hosts and patients with biliary disease, malignancy and diabetes mellitus (DM). It has a reported mortality of approximately 50% (2) . We experienced a rare case of enterocolitis, sepsis and liver abscess in an 85-year-old woman that was caused by E. tarda. She had DM, which is considered to be a risk factor for the E. tarda infection. She survived following intensive care, which included mechanical ventilation, vasopressors, an anticoagulant agent and continuing antibiotics.
Case Report
An 85-year-old woman was admitted to our hospital with nausea and diarrhoea that had occurred on the previous day. She had a history of thyroid carcinoma, which had been successfully treated by thyroidectomy, as well as DM and hypertension. She did not smoke or consume any alcohol.
Physical examination showed a high fever of 38. 4 and tachycardia with a heart rate of 112 beats/min. Her breath and heart sounds were clear. She had no rash on her skin or lymphadenopathy. Her abdomen was soft, and she had no pain in response to abdominal pressing or rebound tenderness.
The laboratory data showed a white blood cell (WBC) count of 5.1×10 3 /μL, platelet (Plt) count of 8.2×10 4 /μL, a haemoglobin concentration of 13.8 g/dL, a prothrombin time international-normalized ratio (PT-INR) of 1.16, a C-reactive protein (CRP) level of 8.84 mg/dL and urinary WBC sediment of 30-40/high power field (Table 1) .
Plain computed tomography (CT) showed swelling of the small intestine, a fatty area around the kidneys bilaterally and a low-density area in segment 6 of the liver, which had been previously observed as a cyst, but had now appeared to have increased in size in comparison to 3 months previously ( Fig. 1, 3) . CT was performed without contrast enhancement, so the low-density area in the liver could not be clearly distinguished as either a simple cyst or an abscess.
After hospitalization, her body temperature gradually increased, her systolic blood pressure decreased to approximately 70 mmHg and hypoxaemia developed. Her course demonstrated a rapid progression and she was thus diag- nosed to have systemic inflammatory response syndrome (SIRS). She was intubated, put on mechanical ventilation and administered vasopressors in the intensive care unit (ICU). We diagnosed her to have severe septic shock, and therefore meropenem and gamma globulin were administered. The laboratory data after admission showed declines in Plt (from 8.2 to 4.4 10 4 /μL) and PT-INR (from 1.16 to 1.35). As a result, she was diagnosed with disseminated intravascular coagulation syndrome and therefore was administered anticoagulation therapy. Her blood pressure and respiratory condition improved, and her fever gradually subsided. She was extubated on the 6th day after admission. E. tarda was detected in both blood and stool specimens, and 10 7 colony-forming units of Escherichia coli were detected in her urine. Based on these findings, we diagnosed her to have enterocolitis and sepsis caused by E. tarda and urinary tract infection caused by E. coli. She showed satisfactory progress and left the ICU on the 7th day. However, on the same day, she again developed a fever along with an increase in her WBC (Fig. 2) . Her urinary tract infection improved, and contrast-enhanced CT on that day showed a liver abscess that measured 3 cm at the border of segment 6 (Fig. 3) . We thought that the liver abscess had been responsible for both the fever and inflammatory response and then punctured the abscess. The removed fluid was turbid, and fresh neutrophils were observed and E. tarda was later identified in a fluid specimen. Her fever, CRP and WBC all gradually improved. We changed the antibiotics from meropenem to oral levofloxacin on the 12th day because the identified E. tarda was susceptible to most antibiotics. However, on the 16th day, her CRP increased. As a result, the therapy was changed to sulbactam/ampicillin. The inflammatory response gradually improved, but on the 30th day she again developed fever. The emergence of a drug-resistant strain was suspected, and we again started her on meropenem. Following this change, the patient responded satisfactorily. The liver abscess decreased to 1 cm in size at the border on the 31st day (Fig. 3) . Oral cefcapene was commenced on the 40th day. She was eventually discharged on the 44th day and continued to receive cefcapene for another 5 days. She has since been doing well and has not had a recurrence of the infection.
Discussion
E. tarda has been isolated from freshwater and marine environments and also from animals that live in these environments. In humans, the organism is an uncommon pathogen which has been generally associated with an asymptomatic carrier state (1) . Dietary habits may be relevant to the acquisition of this organism. Infection mostly causes gastrointestinal disease following ingestion. However, extragastrointestinal infections have also been reported including soft tissue infection, sepsis, hepatobiliary infection, intra-abdominal abscess, wound infection, meningitis, peritonitis, osteomyelitis, endocarditis, tubo-ovarian abscess, empyema and salpingitis (3-11). They develop in both immunocompromised hosts and in patients with DM, malignancy, hepatobiliary disease and haematological disease. Interestingly, it also develops in conditions associated with iron overload, status such as in patients demonstrating sickle cell disease, cirrhosis, leukemia and in neonates (2, 3) . Almost all E. tarda strains are susceptible to antibiotics with an activity against Gramnegative bacilli, including most beta-lactams, aminoglycosides, tetracyclines, fluoroquinolones and antifolates (12) .
In this case, the patient lived near the sea, often ate fresh fish and had DM, which was considered to be risk factors for E. tarda infection. We suspected that E. tarda had thus caused the gastroenteritis, which then developed into sepsis and a liver abscess in this patient.
Our hospital encountered 13 patients with bacteraemia of E. tarda over the last 6 years from 2006 to 2011 (Table 2) . Five patients had advanced malignancy. Eight patients, four of whom had malignancy, had sepsis (SIRS and bacteraemia), and five of them died during the course of their dis- ease, whereas the other five patients without sepsis survived. Although E. tarda is susceptible to almost all antibiotics, septic shock from E. tarda is said to have close to a 50% mortality (2) . This rate is similar to that experienced at our hospital, even though the underlying disease in some patients might have been the actual cause of death. The presence of an underlying disease in these patients, such as cancer or hepatobiliary disease, might also be a poor prognosis factor.
In this case, the patient had no severe complications, such as cancer, which might be one reason why she survived the state of septic shock. In addition, early antibiotic therapy appeared to be effective in this case. However, her course was complicated. She had recurring fever and an enhanced inflammatory response. We punctured the abscess and changed the antibiotics. Surgical management for appropriate drainage at the infected site is sometimes needed, and the maintenance of appropriate antibiotics appears to be essential for controlling sepsis completely.
There are few reports on bacterial sepsis and this occurrence is therefore not familiar to physicians. However, the fact that our hospital has experienced 13 such patients in 6 years seems to suggest that such cases of sepsis may be missed at many hospitals. Since Japan is an island country that is surrounded by the sea, it may experience more such cases than other countries.
In summary, although E. tarda sepsis is rare, it is nevertheless a life-threatening illness which can cause intestinal and extraintestinal infections in healthy patients. Therefore, the presence of sepsis needs to be identified as early as possible while administering timely and appropriate management with antibiotics, intensive care and surgical procedures according to the infection site in order to save the life of such patients.
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